Quarterly report · Q3
4598.TEDINET S100Q8SE
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedNo
Data checks8 of 8 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥1.0bn | 2022-04-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥833m | 2021-04-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.0bn | 2022-04-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥964m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥835m | 2021-04-01 → 2021-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥1.0bn | 2022-04-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥835m | 2021-04-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | −¥1.0bn | 2022-04-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥967m | 2021-04-01 → 2022-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥838m | 2021-04-01 → 2021-12-31 | Standalone | Profit loss |
| Total assets | ¥953m | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2021-12-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥202m | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥91m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥751m | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-12-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥887m | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-190.18 | 2022-04-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-75.04 | 2022-10-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-178.58 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-154.65 | 2021-04-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-51.68 | 2021-10-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.4% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.5% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 6,054,700 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,419,600 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,419,600 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 223
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)Delta-Fly Pharma株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の５ | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration_NonConsolidatedMember | Original text (Japanese)当社は、医薬品事業のみの単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 8 of 8 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |